To address a continuing nationwide shortage, more than 77,000 doses of RSV shots for infants were released Thursday by the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration.
Nov 16, 2023
0
46
Demand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants.
Oct 24, 2023
0
39
Every winter, Canadian pediatric hospitals experience a wave of admissions linked to respiratory syncytial virus (RSV), one of the leading causes of hospitalization among children. These hospitalizations represent a major ...
Oct 4, 2023
0
33
National medicine regulator, the Food and Drug Administration (FDA), recently approved the world's first vaccines to prevent RSV, or respiratory syncytial virus, for infants and elderly adults.
Sep 14, 2023
0
49
Ask Danielle Palmieri when her newborn son contracted RSV, and she doesn't give a season or even a month. She knows the exact day.
Sep 7, 2023
0
52
All infants should receive the new long-acting preventive monoclonal antibody for respiratory syncytial virus (RSV), the nation's leading pediatrics group said.
Aug 16, 2023
0
32
Most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term, according to a new study reported in JAMA Network ...
Aug 15, 2023
0
49
This winter, we're having to get our heads around another respiratory virus—RSV.
Jul 26, 2023
0
34
The first vaccine against respiratory syncytial virus (RSV) has been approved by the US Food and Drug Administration. The vaccine, named Arexvy, will be given to people 60 years and older.
May 10, 2023
0
32
Does immunizing a woman during pregnancy protect her unborn baby against respiratory syncytial virus (RSV) in the months after it is born?
Apr 6, 2023
0
53
